tiprankstipranks
Trending News
More News >
Anpario (GB:ANP)
LSE:ANP

Anpario (ANP) AI Stock Analysis

Compare
15 Followers

Top Page

GB:ANP

Anpario

(LSE:ANP)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 4o)
Rating:78Outperform
Price Target:
587.00p
▲(22.29% Upside)
Anpario's strong financial performance and positive corporate events are the most significant factors driving the score. The technical analysis supports a bullish outlook, while the valuation is fair. The absence of specific earnings call data does not impact the overall positive assessment.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.
Balance Sheet Health
A strong balance sheet with low leverage enhances financial stability, providing flexibility for investments and weathering economic downturns.
Profitability
Improved profitability margins reflect efficient operations and cost management, contributing to sustainable earnings and shareholder value.
Negative Factors
Operating Cash Flow Decrease
A decline in operating cash flow can signal potential liquidity issues, affecting the company's ability to fund operations and growth initiatives.
Monitoring Cash Flow Trends
Monitoring cash flow trends is crucial as it impacts reinvestment capabilities and financial health, potentially affecting future growth.
Cash Flow Management
While cash management is effective, a recent dip in operating cash flow could impact strategic investments and necessitates careful oversight.

Anpario (ANP) vs. iShares MSCI United Kingdom ETF (EWC)

Anpario Business Overview & Revenue Model

Company DescriptionAnpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salgard, Salkil, Genex, and Optimax brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Salkil, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products, such as water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, Red Lite, and Clean & Dry brands; and toxin management category products, such as mycotoxin binders under the Anpro, Ultrabond, and Neutox brands. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
How the Company Makes MoneyAnpario generates revenue primarily through the sale of its feed additives and nutritional products to farmers, feed manufacturers, and distributors worldwide. The company has established key revenue streams from its diverse product portfolio, which includes specialty products that cater to specific animal health needs. Additionally, Anpario benefits from strategic partnerships with distributors and agricultural businesses that allow for broader market access and customer reach. The company also invests in research and development to innovate and enhance its offerings, ensuring that it meets the evolving demands of the agricultural sector, which in turn contributes to its earnings.

Anpario Financial Statement Overview

Summary
Anpario presents a strong financial profile with consistent revenue and profit growth, supported by efficient operations. The balance sheet indicates solid financial health with low leverage and strong equity. Cash flow generation is robust, although recent trends in operating cash flow should be monitored. Overall, the company is well-positioned for sustainable growth and stability.
Income Statement
88
Very Positive
Anpario has demonstrated consistent revenue growth, with a notable increase from 2023 to 2024. The gross profit margin has been stable, and the net profit margin has improved, indicating enhanced profitability. The EBIT and EBITDA margins have also shown strength, reflecting efficient operations. Overall, the income statement reflects solid growth and profitability.
Balance Sheet
85
Very Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating prudent financial management. The equity ratio is healthy, suggesting a strong capital position. Return on equity is robust, showcasing effective utilization of shareholder investments. The balance sheet reflects financial stability and low leverage risk.
Cash Flow
80
Positive
Anpario's cash flow metrics are positive, with strong operating cash flow compared to net income, indicating good cash generation. Free cash flow has grown, supporting business reinvestment and shareholder returns. The cash flow statement shows effective cash management, although a decrease in operating cash flow in the latest year warrants attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue43.93M38.20M31.00M33.10M33.37M30.52M
Gross Profit21.24M17.34M13.96M13.49M15.53M15.20M
EBITDA7.67M6.38M4.00M4.91M6.98M6.59M
Net Income5.14M4.11M2.53M3.30M4.68M4.21M
Balance Sheet
Total Assets48.44M47.15M40.19M48.53M47.98M44.48M
Cash, Cash Equivalents and Short-Term Investments11.10M10.50M10.65M13.57M15.54M15.82M
Total Debt86.00K74.00K79.00K52.00K85.00K90.00K
Total Liabilities9.38M10.85M6.54M7.22M7.68M6.97M
Stockholders Equity39.05M36.29M33.65M41.31M40.30M37.51M
Cash Flow
Free Cash Flow2.22M4.20M7.95M-329.00K1.78M4.66M
Operating Cash Flow4.32M6.14M8.70M1.21M3.20M5.92M
Investing Cash Flow-4.84M-4.18M1.21M-1.44M-1.42M-1.26M
Financing Cash Flow-1.65M-1.54M-10.96M-1.96M-2.01M-2.52M

Anpario Technical Analysis

Technical Analysis Sentiment
Negative
Last Price480.00
Price Trends
50DMA
491.30
Negative
100DMA
480.46
Negative
200DMA
441.44
Positive
Market Momentum
MACD
-4.23
Negative
RSI
41.09
Neutral
STOCH
31.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ANP, the sentiment is Negative. The current price of 480 is above the 20-day moving average (MA) of 479.40, below the 50-day MA of 491.30, and above the 200-day MA of 441.44, indicating a neutral trend. The MACD of -4.23 indicates Negative momentum. The RSI at 41.09 is Neutral, neither overbought nor oversold. The STOCH value of 31.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ANP.

Anpario Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£79.65M15.5113.81%2.42%34.26%71.40%
71
Outperform
£456.23M11.6512.72%7.01%8.58%-15.81%
70
Outperform
£1.19B20.6612.23%0.79%7.74%30.09%
64
Neutral
£72.48M21.373.14%
64
Neutral
£1.49B38.955.88%2.52%0.59%-41.66%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ANP
Anpario
475.00
36.43
8.31%
GB:FVA
Carr's Group plc
140.00
18.88
15.59%
GB:HFG
Hilton Food
508.00
-335.20
-39.75%
GB:ZAM
Zambeef Product
4.65
0.97
26.36%
GB:GNC
Greencore
273.50
92.63
51.21%
GB:BAKK
Bakkavor Group plc
252.00
117.75
87.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025